Systems and methods for locating and measuring light in light-scattering media.

By combining ultrasonic transducers and optical filters, high light intensity measurements of light-scattering media are performed using frequency-shifted optical signals. This overcomes the limitations of optical imaging methods in terms of penetration depth and resolution, enabling measurements of deeper biological tissues.

CN123124924APending Publication Date: 2026-11-17DEEP LIGHT VISION AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202580022429.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2024-03-20
Filing Date
2025-03-20
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing optical imaging methods are limited in penetration depth and spatial resolution in light-scattering media, making it difficult to measure high light intensity inside tissues.

Method used

An ultrasonic transducer is used to guide the ultrasonic field and combine it with an optical filter and a photodetector to measure the high light intensity inside the tissue through frequency-shifted optical signals. Multiple light sources and detectors are used, combined with a slow light filter and a processing unit for image reconstruction.

Benefits of technology

It improves the penetration depth and spatial resolution of light in light scattering media, enabling high light intensity measurement inside tissues, especially achieving deeper oxygen saturation measurement in biological tissues.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123124924A_ABST
    Figure CN123124924A_ABST
Patent Text Reader

Abstract

A system for measuring light in an object, the system comprising at least one ultrasonic transducer; at least one light emitter configured to emit light from at least two locations or through a covered extended area; at least one optical filter; at least one photodetector for detecting frequency-shifted light; and wherein the detected frequency-shifted light from at least two locations or the extended area is processed to provide information on at least one location within the tissue site.
Need to check novelty before this filing date? Find Prior Art

Description

Background of the Invention Technical Field

[0001] This disclosure generally relates to apparatus and methods for selectively obtaining light deep within a light-scattering medium, such as biological tissue. More specifically, this disclosure relates to an apparatus and method for using light deep within a scattering medium to achieve more localized measurements than those achievable by conventional methods. In particular, this disclosure relates to using acoustically offset lasers and optical components to achieve localized light measurements deep within a scattering medium.

[0002] Public background

[0003] The ability to illuminate turbid (i.e., light-scattering) media is important in many environments, including but not limited to biomedical applications. Optical imaging provides highly sensitive molecular contrast in a simple and non-invasive manner. Conventional optical microscopy relies on light penetrating shallow layers of approximately tens of micrometers. Confocal microscopy extends the penetration depth to approximately 0.1 mm, while optical coherence tomography (OCT) reaches depths of approximately 0.5 mm. This is roughly the limit of high-resolution optical imaging modalities, which rely on suppressing diffuse scattering. At deeper depths, diffuse light scattering dominates the interaction between the light field and the medium. The attenuation of the incident beam at a certain depth is largely determined by the scattering of the medium. This fundamental aspect means that even at the most favorable wavelengths in the near-infrared region, the maximum penetration depth that light can be detected in typical biological tissue is limited to approximately 10 cm.

[0004] Other optical analysis and imaging modalities have been developed for diffuse scattering conditions (ranging from approximately one millimeter to several centimeters). One example is pulse oximetry for determining blood oxygen saturation. An example of optical imaging is diffuse optical tomography, which can be performed, for example, using endogenous tissue contrast, with added contrast agents, in a fluorescent manner, or with added fluorescent agents. Generally, due to diffuse scattering, these methods limit spatial localization to approximately a few millimeters to one centimeter or larger. Furthermore, because the intensity of the detected light is very low, the detection protocols are typically cumbersome, slow, and require advanced and expensive equipment.

[0005] To improve spatial localization when using light to probe turbid media, photoacoustic schemes have been designed. In photoacoustic tomography, acoustic waves locally generated due to the slight heating of tissue caused by the absorption of laser pulses are detected by an ultrasonic transducer. Photoacoustic tomography takes advantage of the fact that ultrasound waves scatter in tissues at a rate several orders of magnitude lower than light waves. Therefore, the spatial localization of the acoustic wave origin can be approximately one millimeter or less. The depth achievable by photoacoustic tomography is fundamentally limited by the acoustic background noise of the medium. This means that photoacoustic imaging in living human tissue is limited to a maximum of approximately 2 cm.

[0006] Another example of using acoustics to improve the localization of light interactions in tissues is the use of acoustic photon labeling, as described, for example, in J. Gunther and S. Anderson-Engels (October 2017), Review of current methods of acousto-optical tomography for biomedical applications, Frontiers of Optoelectronics, 10(3), 211-238. By allowing sound to penetrate tissue and guide a laser into it, only the laser passing through the area occupied by the sound field is frequency-shifted by the sound frequency. By optically detecting only the frequency-shifted light, it can be known that the light has interacted with the sound field, which occupies a small and localized volume compared to light. This scheme is called ultrasound optical tomography (UOT). Unlike photoacoustic tomography, this scheme is not limited by acoustic background noise, but only by the ability to measure optical signals. This allows for imaging of tissues at significantly deeper depths (>5 cm).

[0007] In ultrasound-modulated optical tomography (UOT), researchers attempt to detect minute changes in signal due to varying optical properties of tissue. However, photon flux within tissue varies, resulting in greater background variation. These differences in photon flux are usually compensated for, making it easier to extract small signal changes caused by tissue optical properties. In Kim et al., Sentinel lymphnode detection ex vivo using ultrasound-modulated optical tomography, J Biomed Opt. 2008, 13(2) 020507 and Kim et al., Ultrasound-modulated optical tomography in reflection-mode with ring-shaped light illumination, J Biomed Opt. 2009, 14(2) 024015, they used a ring-shaped light illumination scheme to provide more uniform illumination within the tissue compared to previous light illumination techniques.

[0008] Although photoacoustic methods can provide better spatial resolution than purely optical methods, these methods are still limited by the fact that light does not easily penetrate into the light-scattering medium due to the strong attenuation provided by scattering.

[0009] As described above, previously known methods for performing optical measurements within light-scattering media have limited penetration depth and / or poor spatial resolution. Therefore, new and improved apparatuses and methods for deep light penetration in light-scattering media would be advantageous. Summary of the Invention

[0010] Therefore, the examples of this disclosure are preferably intended to mitigate, alleviate or eliminate one or more defects, shortcomings or problems in the art (such as those pointed out above) in a manner that alone or in any combination, by providing an apparatus, system or method according to the appended patent claims, for selectively obtaining high light intensity deep within the scattering medium for the purpose of localized light measurement.

[0011] In a first aspect, this disclosure relates to a system for measuring light in humans or animals. The system includes at least one ultrasonic transducer and at least one light emitter for emitting light over an extended region in the wavelength range of infrared (IR) light, such as near-infrared (NIR), visible light, or ultraviolet light. The system may also include at least one optical filter, at least one photosensor, and a processing unit.

[0012] An ultrasonic transducer may be configured to direct at least one ultrasonic field having at least one ultrasonic frequency to at least one location within the tissue of the human or animal. At least one light emitter may be configured to direct light having at least one optical frequency from at least two locations or through a covered extended area into the tissue of the human or animal.

[0013] At least one optical filter may be arranged in front of at least one photodetector to suppress the light frequency, but transmit light having at least one light frequency shifted by the ultrasonic frequency.

[0014] At least one photodetector detects light that has been frequency-shifted by ultrasound, and the processing unit can process the detected frequency-shifted light from the at least two locations or extended regions to provide information on at least one location within the tissue site.

[0015] In one example, at least one light emitter may be at least two light sources, such as lasers, which are arranged to direct light from different discrete locations into the tissue site.

[0016] In one example, at least one light emitter may be a single light source extending over an extended region, wherein the single light source is arranged to direct light from the extended region to the tissue site.

[0017] In one example, at least one optical detector can be at least two optical detectors or a spatially resolved detector.

[0018] In one example, at least one optical filter may be at least one crystal, and a single crystal is arranged in front of each of the at least two photodetectors, or a single region of a single crystal is associated with a segment of each of the at least two detectors or a spatially resolved detector.

[0019] In one example, the reflector may be arranged to direct light to a separate portion of at least one crystal, and from each separate portion to a separate segment of a separate detector or a spatially resolved detector among the at least two detectors.

[0020] In one example, the processing unit may use information related to the location of the emitted light and the location of the detected frequency-shifted light to provide information about at least one location within the tissue site.

[0021] In one example, the processing unit provides a reconstruction, such as an image, of at least one location within the tissue site.

[0022] In one example, at least one ultrasonic transducer may be configured to scan a 3D volume or be translated.

[0023] In one example, at least one light emitter can be configured to emit light corresponding to at least two different wavelengths.

[0024] In one example, the system may also include at least one of time-of-flight, frequency-domain photon migration spectroscopy, or diffusion optical tomography to provide optical properties of the tissue.

[0025] In one example, optical properties are used to improve resolution and / or contrast.

[0026] In one example, at least one optical emitter can be stabilized to a certain wavelength or frequency by means of an external optical cavity, by locking the wavelength or frequency to a spectral aperture in a crystal, or by locking the wavelength or frequency to a fiber optic interferometer or fiber optic cavity.

[0027] In one example, a reference may be obtained by measurement at at least one individual location, or by simulation using a diffusion equation or Monte Carlo method, wherein the reference is removed from information from at least one location within the tissue site.

[0028] In one example, information about at least one location within a tissue site can be obtained as a function of time and combined with body cycles to extract additional information.

[0029] It should be emphasized that the term "light" used in this specification is not limited to light visible to the human eye, but also includes wavelengths in the ultraviolet and infrared regions, such as near-infrared.

[0030] In the context of this application, the term "extended region," relative to the light source and detector, may mean that the region of the light source and detector covers an area larger than the end surface of a single diode or optical fiber. For example, for a light source, this could be a 1D or 2D array with continuous or smooth emission across the entire surface of the source without discrete emission points. This can be achieved using a light diffuser. For a light source, an extended region can also be obtained by using optics to spread a laser beam to inject light onto the extended region. Alternatively, when light is emitted from an optical fiber, the extended region can be obtained by diverging the light, for example, by holding the end of the optical fiber at a certain distance from the tissue surface.

[0031] Alternatively, a diffuser can be used to obtain an "extended region". The diffuser can be a flat diffuser made of a plate of material used as a waveguide, in which light is transmitted and emitted to the tissue site.

[0032] Furthermore, the term "extended region," relative to the light source, can mean multiple light injection sites distributed across the surface. These light injection points may not be discrete light injection points, but rather part of a continuous light-emitting surface.

[0033] It should also be emphasized that the term "including / comprises" as used in this specification specifies the presence of the stated features, integers, steps, or components, but does not exclude the presence or addition of one or more other features, integers, steps, components, or groups thereof. Attached Figure Description

[0034] Referring to the accompanying drawings, these and other aspects, features, and advantages that can be achieved by the examples of this disclosure will become apparent and will be elucidated from the following description of the examples, wherein:

[0035] Figure 1 An example of a schematic setup for imaging using acoustic photon markers is shown.

[0036] Figure 2 These are images obtained from three experiments using ultrasound optical tomography (UOT) signals. The tissue mockups have optical properties similar to tissue, and each image contains inclusions with varying relative absorption coefficients compared to the background tissue. The figure also shows the ultrasound image for each experimental case. Figure 1 The system example is used to measure the UOT signal.

[0037] Figure 3 A schematic crystal with three different types of doped ions is illustrated. This crystal can be used to manufacture slow-light filters.

[0038] Figure 4An example of a slow-light filter is shown. The absorption of different ion types in the crystal has been manipulated, allowing frequency-shifted light (solid line) to pass through while the original laser frequency (dashed line) is absorbed.

[0039] Figure 5 The most likely path for a photon to travel from the source (19) through the ultrasound focus (15) before leaving the tissue (20) and being detected is schematically illustrated.

[0040] Figure 6 The illustration shows the case when three sources and three detectors are used, showing that all photon paths travel through the ultrasonic focus (15), but in other cases, very different paths may be taken.

[0041] Figure 7 The illustration shows the situation when using an extended source and detector, again showing that all photon paths travel through the ultrasonic focus (15), but in other cases, very different paths may be taken (shown by color gradients).

[0042] Figure 8 illustrates the use of a source and detector ( Figure 8a or multiple sources and detectors Figure 8b Monte Carlo simulation results of the UOT signal (left figure), and Jacobian matrix diagram of the influence of the UOT signal (black circle in the left figure) on the optical properties of the tissue (right figure).

[0043] Figure 9 This illustrates an example of how the absorption coefficient can vary as a function of wavelength for different tissue types (skin, fat, glands, and tumors) assuming a specific concentration of some tissue chromophores.

[0044] Figure 10 This demonstrates a compact design that allows the locking crystal to be mounted inside a cryostat with a ring sleeve and a gradient refractive index lens (GRIN).

[0045] Figure 11 A flowchart illustrating an exemplary method for imaging using acoustic photon markers is shown. Detailed Implementation

[0046] The following disclosure focuses on its application to improving the localization of light interactions in a light-scattering medium for photometric purposes. This disclosure can be applied to the measurement of oxygen saturation deep within living tissues, such as the brain, heart, female breast, or muscle tissue. However, it should be understood that this description is not limited to this application but can be applied to many other systems in which the localization of light interactions in a light-scattering medium is useful.

[0047] In general, this disclosure relates to an optical and ultrasonic component combined within a tissue, with the optical component exiting the tissue being filtered by an optical filter before being detected and analyzed by the processing unit. This application relates to the use of multiple or extended light sources, multiple or extended detectors, and multiple regions or individual areas of a crystal as optical filters. Optical light can be transmitted between the tissue and the crystal via a reflector and from the crystal to the detector. Furthermore, the frequency of the optical light can be stabilized using an external optical cavity or by locking the frequency to a spectral aperture in the crystal. This disclosure also relates to how the processing unit can reconstruct tissue properties or extract information from measurements using prior knowledge, for example, information from conventional medical techniques or from additional measurements performed using other ultrasonic or optical methods. Furthermore, this disclosure relates to using multi-wavelength optical light to better extract useful information about tissue composition. The ultrasonic component can also cover a 3D volume by scanning or translating, which is important when the measured information is used to reconstruct tissue properties. This disclosure may also relate to how reconstruction can be improved by taking reference measurements at different spatial locations or by using diffusion equations or Monte Carlo simulations. Furthermore, this disclosure may relate to how to improve reconstruction or measurement by performing measurements over time and synchronizing the measurements with the body's cycles.

[0048] In the example, Figure 1 In the schematic diagram, system 100 includes an optical portion comprising at least one light source 12 (such as a laser) and an optical filter 14. The at least one light source can be configured to emit light guided from at least two locations or to cover an extended area. The acoustic portion of the system includes an ultrasonic device 13. The ultrasonic device 13 emits a sound field into a light-scattering medium 11 to occupy a point 15. A beam 18a emitted from the laser 12 is guided into the medium 11, and the beam 18a is diffusely reflected 18b within the medium. A portion of the diffused light 18b can pass through the location occupied by the ultrasonic field 15 and can be frequency-shifted through interaction with the ultrasonic field. The ultrasonic frequency can be approximately 10 Hz. 6 Hz, while the optical frequency can be approximately 10 Hz. 14 Hz. Since the optical frequency of a laser is many orders of magnitude higher than that of ultrasound, the frequency shift corresponds to a small wavelength difference in the laser, which can be approximately a few nanometers. The frequency-shifted light can diffusely propagate through the medium from the location occupied by the ultrasonic field 15, and a portion of the frequency-shifted light 18c may leave the medium and strike the optical filter 14. The optical filter 14 largely removes the original laser frequency, thus essentially leaving the detectable frequency-shifted light. The optical filter 14 needs to have special characteristics to separate the frequency-shifted light into approximately 10 Hz. 6 Suppression of approximately 10 at Hz 14The carrier frequency is Hz. It also needs to be largely independent of the angle of the incident light, which is diffuse. This property can be achieved as a so-called slow light filter, as described in H. Zang et al. (March 2012), Slow light for deep tissue imaging with ultrasound modulation, Appl. Phys. Lett. 100(13), 131102. The frequency-shifted light mainly carries information from position 15, and thus this setting provides spatial information about the interior of medium 11. By scanning position 15 (representing the volume occupied by ultrasound), a spectrum or image of the optical contrast within medium 11 can be obtained, such as information about oxygen saturation in the tissue. Lateral scanning can be performed by mechanical movement of the ultrasound source or by electronically moving the ultrasound field by controlling the various elements of the ultrasound source. Longitudinal scanning is performed by timing the light pulse to different depth positions of the ultrasound pulse or by timing the light measurement to different depth positions of the ultrasound pulse while illuminating the tissue with continuous wave (cw) light or quasi-cw light. Experimental images obtained in this way are as follows Figure 2 The figure shows images obtained from three experiments using ultrasound optical computed tomography (UOT) signals. The tissue mockups have optical properties similar to tissue, and each image contains inclusions with varying relative absorption coefficients compared to the background tissue. The figure also shows ultrasound images for each experimental case. In the ultrasound images, dashed squares have been added to highlight the areas containing inclusions.

[0049] exist Figure 2 In the measurement, position 15 has already been scanned in the high absorption region, i.e., for low oxygen saturation at wavelengths shorter than 800 nm. To extract information about oxygen saturation, it is preferable to perform the measurement using at least two different wavelengths. For example, it is preferable to have one wavelength at approximately 800 nm and another wavelength in the range of 600 nm to 770 nm. The spectral absorption curves of oxygen-saturated and non-oxygen-saturated hemoglobin result in similar light absorption at approximately 800 nm, but differ at wavelengths below or above 800 nm. Alternatively, one wavelength at approximately 800 nm and another wavelength in the range of 820 nm to 1200 nm can be selected. By comparing the signals at these two wavelengths, the ratio of oxygen-saturated to non-oxygen-saturated hemoglobin can be inferred. It should be noted that the method is not limited to two wavelengths. In some cases, it may be more advantageous to use more than two wavelengths, for example, to improve accuracy when measuring oxygen saturation.

[0050] Optical filter 14 can be constructed from a slow-light filter, as exemplified in... Figure 3 and Figure 4The slow-light effect is achieved by creating a narrow-band spectral transmission window in a background of strong absorption, which, according to the Cramé-Kleinich relation, leads to strong dispersion and thus a slow group velocity, i.e., the slow-light effect. The filter can be constructed from a host crystal 21 doped with ions 22, which have strong absorption at the original frequency of the laser 23. When these ions replace other atoms in the host crystal, they may slightly distort its lattice 21. Although the individual absorptions of these ions are strong and narrow at frequencies, the entire doped ion system may experience different crystal fields and therefore vary slightly from one another at the absorption frequencies. Figure 3 The text describes three different types of ions22, which have different energy intervals between the ground state and excited state, such as... Figure 3 As shown in b), a large number of different ion species produce the total absorption curve of the doped ion system in the host crystal, which is two to three orders of magnitude wider in frequency than any frequency shift caused by the acoustic field.

[0051] Within this absorption curve, different persistent spectral structures can potentially be constructed using optical pumping techniques. This optical pumping can be performed with or without an applied electric and / or magnetic field to split the ion energy levels. Examples of the resulting filter and crystal absorption curves are shown below. Figure 4 As shown, absorption of the original laser frequency 23 may be unaffected or even higher, while any absorption of the frequency-shifted light 24 may be removed, which can then proceed to detector 25. A side effect of this modified absorption profile is that the group velocity of the frequency-shifted light may be reduced by several orders of magnitude. Therefore, signal 24 can be additionally distinguished from the original laser 23 via time gating.

[0052] The spatial information carried by the frequency-shifted light mainly comes from the location of the ultrasonic field at point 15. However, since the light propagates from the light input point 19 through the ultrasonic focus 15 to the output aperture 20, the frequency-shifted light will be affected by any absorption present in the propagation path from 19 through 15 to 20.

[0053] This means that although the UOT signal is mainly located at the ultrasound focal point 15, it will also be affected by absorption along this path, such as... Figure 5 As indicated, the signal is "smeared" or blurred, which reduces the spatial resolution of the technique unless a more refined lighting and detection scheme is used, or a complex reconstruction algorithm is employed to compensate for the blurring effect.

[0054] To improve spatial resolution and thereby reduce image blur, it is advantageous to have multiple light injection sites distributed across the surface (see [link]). Figure 6 ), or large-area lighting (see Figure 7 This is to reduce the impact of image blurring because multiple light propagation paths are involved at different angles. Furthermore, multiple light collection locations are distributed across the surface ( Figure 6 ) or large-area light collection ( Figure 7 This can increase the number of light propagation paths at different angles.

[0055] The processing unit processes detected frequency-shifted light from the at least two locations or from a light source covering the extended area to provide information about at least one location within the tissue site.

[0056] Data processing devices, processing units, or computing devices may be implemented by specialized software (or firmware) running on one or more general-purpose or special-purpose computing devices. In this context, it should be understood that each “element” or “component” of such a computing device refers to a conceptual equivalent of a method step; there is not always a one-to-one correspondence between an element / component and a specific hardware or software routine. A piece of hardware may sometimes include different components / elements. For example, a processing unit may act as one element / component when executing one instruction, but as another element / component when executing another instruction. Furthermore, an element / component may be implemented by one instruction in some cases, but by multiple instructions in others. Such software-controlled computing devices may include one or more processing units, such as a CPU (“Central Processing Unit”), a DSP (“Digital Signal Processor”), an ASIC (“Application-Specific Integrated Circuit”), discrete analog and / or digital components, or some other programmable logic device (such as an FPGA (“Field-Programmable Gate Array”)).

[0057] Data processing equipment, processing units, or computing devices may also include system memory and a system bus that couples various system components, including system memory, to the processing unit. The system bus can be any of a variety of bus architectures, including memory buses or memory controllers, peripheral buses, and local buses using any of a variety of bus architectures. System memory may include computer storage media in the form of volatile and / or non-volatile memory, such as read-only memory (ROM), random access memory (RAM), and flash memory. Specialized software may be stored in system memory or on other removable / non-removable, volatile / non-volatile computer storage media (such as magnetic media, optical media, flash memory cards, digital magnetic tape, solid-state RAM, solid-state ROM, etc.) that are included in or accessible by the computing device. The processing unit may include one or more communication interfaces, such as serial interfaces, parallel interfaces, USB interfaces, wireless interfaces, network adapters, etc., and one or more data acquisition devices, such as A / D converters. Specialized software may be provided to the control unit or data processing device on any suitable computer-readable medium, including recording media and read-only memory.

[0058] Any method, measurement, or calculation described herein can be implemented in a processing unit, data processing device, or computing device. Computer implementation can be performed as a computer program or software to be executed on a control unit, data processing device, or computing device.

[0059] Any method, measurement, or calculation described herein may be performed by a control unit, data processing device, or computing device. The processing unit, data processing device, or computing device may be connected to a system or be a standalone unit.

[0060] The use of a ring light source has been described in Kim et al., Sentinel lymph node detection ex vivousing ultrasound-modulated optical tomography, J Biomed Opt. 2008, 13(2)020507 and Kim et al., Ultrasound-modulated optical tomography in reflection-mode with ring-shaped light illumination, J Biomed Opt. 2009, 14(2) 024015, which has the effect of reducing shadowing effects and unwanted surface modulation. However, these documents do not discuss the optimization of the setup, and they also do not mention multiple sources and / or detectors.

[0061] exist Figure 8a and Figure 8b The image shows a Monte Carlo simulation of the UOT signal in a cross-section of a homogeneous tissue sample (left image) and a Jacobian matrix (right image). This Jacobian matrix indicates the degree to which absorption at each point in the 3D tissue volume affects the UOT signal at the black circle in the left image, by the size of the points. The right image also uses diamonds to indicate the source location, squares to indicate the detector location, and crosses to indicate the location of the ultrasound focal point. Figure 8a In this model, there is only one source and one detector, and the Jacobian matrix indicates that the UOT signal is significantly affected by absorption along the path from the source through ultrasound to the detector. Figure 8b In this study, multiple sources and detectors were used, and in this case, the UOT signal was less dependent on absorption characteristics far from the ultrasound focal point (compared to...). Figure 8a In contrast, it is indicated by smaller points further away from the cross (in contrast). Therefore, the blurring effect is reduced, and the spatial resolution of the UOT technique is improved without the need for additional reconstruction algorithms.

[0062] Measurements using multiple light injection and / or light collection locations can be performed simultaneously or individually, and then combined in post-processing. Furthermore, multiple sources / detectors, or sources / detectors with a large area, or a combination of both can be used.

[0063] Another advantage of distributing multiple light injection points across a surface or providing large-area illumination is that the combined optical flux within the probed volume will be more uniform, such as... Figure 8b The left image and Figure 8a The left image comparison illustrates this. Uniform optical flux is advantageous because it makes it easier to detect small signal variations on a flat background compared to a varying background, where background variation must be compensated for first, potentially introducing additional errors. Furthermore, large variations in optical flux lead to different signal intensities in different parts of the image, with areas of lower signal having a worse signal-to-noise ratio. Therefore, this must be considered in any analysis. In contrast, a uniform light distribution across the region of interest implies more similar signal intensities.

[0064] Another advantage of having multiple individual light injection and / or light collection locations is that prior knowledge of multiple source-detector pairs provides additional information about the optical path that can be used in image reconstruction. This is especially important if one source is activated at a time, and one detector is activated at a time. By doing so, the amount of frequency-shifted photons relative to the number of carrier photons can also be optimized using the primary analysis data, where photons travel through the ultrasonic location with a very high probability as they move from the source to the detector. When one source and detector are activated at a time, each measurement will have a similar... Figure 8a The Jacobian matrix in ) means that the UOT signal at one point will depend on the absorption at many other points, as mentioned above. This is a drawback for a single measurement. However, when information from several such measurements is combined, knowledge of where the injection and light collection locations are can be used to determine where the Jacobian matrix is ​​strongest, and thus additional information can be used to perform tomographic reconstruction of tissue characteristics, for example, similar to what is done in diffuse optical computed tomography.

[0065] Another advantage of injecting light into multiple light injection locations distributed across a surface or illuminating a large area is that more light power can be injected into the medium to increase the signal-to-noise ratio without exceeding the safety limit expressed as the maximum light power per unit area.

[0066] Another advantage of having multiple individual light collection locations is that the light path can be spatially separated into individual crystals or individual portions of a crystal within a slow-light filter. These crystals can be, for example, honeycomb blocks or rectangular blocks, encapsulated close together but with small gaps or other materials that allow incident light in a crystal region to be retained within that region by reflection (e.g., total internal reflection). An additional benefit of this setup is that it is easier to fabricate multiple smaller crystals than to fabricate a single large crystal. Therefore, the total usable detector area can be increased without complicating the crystal growth process. For example, reflective tubes (such as plastic reflective film tubes) can be used to guide light into a cryostat and subsequently to different crystal regions and from these regions to different detectors or different portions of the same detector.

[0067] To improve image reconstruction, it is advantageous to perform scanning of the medium to collect data from a 3D region (volume) larger than the region of interest in the image. Since the detected light has traveled through a large area of ​​tissue, the signal of the frequency-shifted light depends on the optical properties of the entire region the photon may have reached as it travels from the source to the detector. Therefore, it is important to collect data from the entire region to draw better conclusions about the optical properties of the region of interest. This can be achieved by using an ultrasonic transducer capable of scanning a 3D volume, or by mechanically translating the setup. Different information can be obtained by moving the ultrasonic transducer together with the source / detector or independently. Additional resolution or information can be obtained by examining all the collected data simultaneously, rather than limiting the method to examining a 2D slice of data at any single point.

[0068] To improve image reconstruction, it is advantageous to use additional knowledge of the tissue's optical properties, obtainable through other optical methods that can be combined with frequency-shifting methods. Examples of such methods are time-of-flight optical measurements, frequency-domain photon migration spectroscopy, or diffuse optical tomography. Any of these methods can be used to provide an average or low-resolution spatially resolved estimate of the tissue's optical properties. These measurements can be performed using the same laser or different lasers (e.g., VCSELs (vertical-cavity surface-emitting lasers)). These measurements can be performed using the same wavelength as the frequency-shifting method or at different wavelengths (including multiple wavelengths covering a wide spectral range). The information collected can be used as supplementary information to the frequency-shifting method or as prior information in image reconstruction to improve resolution and contrast.

[0069] To further improve image reconstruction, it is advantageous to use additional knowledge about the composition and structure of the medium, which can be provided by other imaging methods such as X-ray imaging, computed tomography, ultrasound imaging, or magnetic resonance imaging (MRI). This provides supplementary or prior information that can aid in image reconstruction, such as spatial information about different tissue regions. Images from methods listed above can be used to locate suspicious areas, which UOT can help characterize. Alternatively, such images can be used to identify different tissue regions, which can be used as prior information in UOT reconstruction to reduce its complexity. UOT can also be used to add false-color information to images from methods listed above. Any MRI data regarding the molecular composition of the tissue can also be used as prior information or combined with UOT information to provide better accuracy and reduce uncertainty in molecular composition.

[0070] like Figure 9 As shown, the absorption coefficient varies considerably for different wavelengths. Furthermore, the absorption coefficient also varies depending on the type of tissue examined (skin, fat, glands, tumors). A potential objective of UOT is to measure the concentration of tissue components (chromophores), such as, but not limited to, water, lipids, deoxygenated and oxygenated blood, collagen, and melanin. However, the UOT signal at a single wavelength is only sensitive to the total absorption coefficient. Therefore, to extract the concentration of several chromophores, at least one wavelength must be used for each relevant chromophore (i.e., for each chromophore that does not contribute negligibly to the total absorption coefficient at any wavelength used for UOT measurement). Therefore, it is important to extend the use of UOT to multiple wavelengths. Alternatively, literature values, reference measurements using other conventional diagnostic techniques (such as X-ray imaging, computed tomography, ultrasound imaging, or magnetic resonance imaging), or methods such as time-of-flight optics, frequency-domain photon migration spectroscopy, or diffusion optical tomography can be used to infer or extract the chromophore concentration of at least one chromophore. This can be performed at a lower spatial resolution than UOT or at a shallower depth than UOT, and this information can then be used in UOT-based reconstruction of chromophore concentration, which can have improved spatial resolution and / or reach deeper into the tissue.

[0071] The main wavelength range that enables deep UOT imaging with reasonable absorption coefficients will be in the range of 600 nm to approximately 1100 nm. Several possible dopants and host crystals that can be used as optical filters exist, including but not limited to: Ho, Er, Eu, Tm, Nd, Dy, Yb, and Pr doped into YLF, LaF3, LiNbO3, or Li6YB(O3)3.

[0072] The UOT method for detecting frequency-shifted light requires an optical emitter (e.g., a laser). Figure 1(12) The light emitter is stabilized at a specific wavelength (frequency). Frequency stabilization is typically achieved using an external optical cavity, which is an expensive and sensitive component. It is advantageous to achieve frequency stabilization through other means that do not require the use of an external optical cavity. Another way to achieve frequency stabilization is by locking the laser frequency to a spectral hole in the crystal, see Julsgaard et al., Understanding laser stabilization using spectral hole burning, OpticsExpress, Vol. 15, No. 18, 11444. Another benefit of stabilizing the laser to a spectral hole is that it may reduce sensitivity to vibrations. Using a spectral hole instead of a cavity can be cost-effective and is technically easier to implement. Spectral holes can be created in the same crystal used for slow light filters or in a separate crystal. If a separate crystal is used, it can be placed in the same cryostat as the slow light filter crystal or in a different cryostat. The input and output of the spectral hole crystal can be made compact by using optical fibers and, for example, GRIN lenses as both input and output to the crystal.

[0073] The locking crystal can be arranged in the ring setting, such as Figure 10 As shown, this is to minimize the size of the locking setup. If the lifetime of the dopant in the crystal is long, its lifetime can be shortened by using an RF field, an electric field, a low magnetic field, or the absence of a magnetic field, or by using a laser.

[0074] When reconstructing blood parameters (including, for example, total blood volume and oxygen saturation), it is advantageous to measure the changes in frequency-shifted optical signals caused by changes in blood pressure during the heartbeat cycle (photoplethysmography).

[0075] When performing image reconstruction and / or data analysis of frequency-shifted optical signals, it is advantageous to apply mathematical models, including light propagation diffusion equations, Monte Carlo (MC) models for light propagation, or artificial neural networks (ANNs), convolutional neural networks (CNNs), recurrent neural networks (RNNs), machine learning (ML), or deep learning. Diffusion equations and MCs can be used to more easily extract information about the spatially resolved optical properties of the medium. They can also be used to compensate for inhomogeneous illumination by subtracting a simulated frequency-shifted optical signal from an experimentally obtained one, thereby compensating for inhomogeneous photon flux and highlighting small differences in frequency-shifted optical signals caused by additional optical scattering or absorption in the tissue.

[0076] MC simulations contain information about how the detected photons travel, and therefore information about how the expected absorption in a voxel will affect the frequency-shifted optical signal at any voxel, which is important for reconstruction.

[0077] ANN, CNN, RNN, and / or ML algorithms can be used in the reconstruction and may be able to detect small UOT signals without compensating for large variations in photon flux due to source / detector locations. Such algorithms can be trained on simulated data obtained through MC simulations or diffusion equations; on UOT experiments performed on tissue phantoms; on UOT experiments performed on healthy volunteers or patients; or on a combination of any of the methods mentioned above.

[0078] In practical implementations of frequency-shifted light methods with slow-light filters, the problem of fluorescence from the filter material mixing with the frequency-shifted light sometimes arises. This can impair the signal or have undesirable effects, namely, the need to wait for the fluorescence to decay (by approximately microseconds to milliseconds) between acquisition events. The fluorescence is sometimes close to the frequency-shifted light in wavelength, but does not completely overlap. To remove or reduce the influence of fluorescence, it is advantageous to use additional optical filters to attenuate the fluorescence before it reaches the photodetector. Examples of such filters include, but are not limited to, interference filters, color filters, other rare-earth crystal filters, rubidium cell filters, or other types of cell filters.

[0079] One method 100 such Figure 11 The example is used for light measurement in the human or animal body.

[0080] At least one ultrasonic transducer is used to direct at least one ultrasonic field 101 having at least one ultrasonic frequency to at least one location inside the tissue of the human or animal.

[0081] Light of at least one optical frequency from at least two light emitters 102 arranged in at least two locations, or from a light emitter covering the extended region, is directed to the tissue site of the human or animal. At least one light emitter is configured to emit light over the extended region in the wavelength range of infrared (IR) light, such as near-infrared (NIR), visible, or ultraviolet light.

[0082] At least one optical filter is used to suppress at least one optical frequency 103. The optical filter is arranged in front of at least one photodetector.

[0083] The light 104, which has been frequency-shifted by ultrasound, is detected by at least one photodetector.

[0084] The detected frequency-shifted light 105 from the at least two locations or extended regions is processed to provide information on at least one location within the tissue site.

[0085] This invention is advantageous when there is a medical interest in measuring tissue oxygenation deep within the body. For example, it can be used in conjunction with ischemic stroke management. In emergency care settings, rapid diagnosis of the presence of ischemic areas in a patient's brain is crucial. A significant proportion of ischemic stroke patients undergo thrombectomy to remove the thrombus. In severe cases, patients cannot remain conscious during thrombectomy, which presents the problem that the success of the intervention is not immediately apparent to the surgeon. In these situations, monitoring brain oxygenation is advantageous as a feedback mechanism to the intervention.

[0086] Another advantageous medical indication for this invention is in emergency procedures for suspected myocardial infarction, to monitor myocardial oxygenation.

[0087] Another medical indication for this invention would be advantageous in sports medicine, for assessing oxygen uptake and metabolism in muscles.

[0088] Another advantageous medical indication for this invention is in the field of oncology, where the oxygen saturation state in tumors may be altered compared to healthy tissue. For example, necrotic areas exhibiting low oxygen saturation may exist within a tumor.

[0089] The invention has been described above with reference to specific examples. However, within the scope of this disclosure, other examples besides those described above are also possible. Within the scope of this invention, method steps different from those described above may be provided. Different features and steps of the invention may be combined in combinations other than those described. The scope of this disclosure is limited only by the appended claims.

[0090] The indefinite articles “a” and “an” used in this specification and claims shall be understood as “at least one / a” unless expressly indicated to the contrary. The phrase “and / or” used in this specification and claims shall be understood as “any one or both” of the elements in such combination, that is, elements that exist in combination in some cases and separately in others.

Claims

1. A system for measuring light in humans or animals, the system comprising: At least one ultrasonic transducer; At least one light emitter, the at least one light emitter being used to emit light over an extended region within the wavelength range of infrared (IR), visible, or ultraviolet light; At least one optical filter; At least one photodetector; and Processing unit; The ultrasonic transducer is configured to direct at least one ultrasonic field having at least one ultrasonic frequency to at least one location within a tissue site of the human or animal; the at least one light emitter is configured to direct light having at least one optical frequency into the tissue site of the human or animal from at least two locations or through an extended region covering the tissue site; the at least one optical filter is disposed before the at least one photodetector to suppress the optical frequency but transmit light having at least one optical frequency shifted by the ultrasonic frequency; the at least one photodetector detects the optical frequency shifted by the ultrasonic frequency; and The processing unit processes the detected frequency-shifted light from the at least two locations or the extended region to provide information about at least one location within the tissue site.

2. The system of claim 1, wherein the at least one light emitter is at least two light sources, such as lasers, the at least two light sources being arranged to direct light from different discrete locations into the tissue site.

3. The system of claim 1, wherein the at least one light emitter is a single light source extending over the extended region, wherein the single light source is arranged to direct light from the extended region to the tissue site.

4. The system according to any one of claims 1 to 3, wherein the at least one photodetector is at least two photodetectors or a spatially resolved detector.

5. The system of claim 4, wherein the at least one optical filter is at least one crystal, and a single crystal is arranged before each of the at least two photodetectors, or wherein a single region of a single crystal is associated with a segment of each of the at least two detectors or the spatially resolved detector.

6. The system of claim 5, wherein the reflector is arranged to guide light to a separate portion of the at least one crystal, and from each of the separate portions to a separate detector of the at least two detectors or a separate segment of the spatially resolved detector.

7. The system according to any one of claims 1 to 6, wherein the processing unit uses information related to the position of the emitted light and the position of the detected frequency-shifted light to provide information about the at least one location within the tissue portion.

8. The system according to any one of claims 1 to 7, wherein the processing unit provides a reconstruction, such as an image, of the at least one location within the tissue site.

9. The system according to claims 1 to 8, wherein the at least one ultrasonic transducer is configured to scan a 3D volume or be translated.

10. The system according to any one of claims 1 to 9, wherein the at least one light emitter is configured to emit light corresponding to at least two different wavelengths.

11. The system according to any one of claims 1 to 10, further comprising at least one of time-of-flight, frequency-domain photon migration spectroscopy, or diffusion optical tomography to provide optical properties of the tissue.

12. The system of claim 11, wherein the optical properties are used to improve resolution and / or contrast.

13. The system according to any one of claims 1 to 12, wherein the at least one optical emitter is stabilized to a certain wavelength or frequency by means of an external optical cavity, by locking the wavelength or frequency to a spectral aperture in a crystal, or by locking the wavelength or frequency to a fiber optic interferometer or fiber optic cavity.

14. The system according to any one of claims 1 to 13, wherein a reference is obtained by measurement at at least one individual location, or wherein a reference is obtained by simulation using a diffusion equation or a Monte Carlo method, and wherein the reference is removed from the information at the at least one location within the tissue site.

15. The system according to any one of claims 1 to 14, wherein the information of the at least one location within the tissue region is obtained as a function of time and combined with body cycles to extract additional information.

16. The system according to any one of claims 1 to 15, wherein the processing unit provides reconstruction of blood parameters.

17. The system of claim 16, wherein the blood parameter is at least one of total blood volume and oxygen saturation.

18. The system according to any one of claims 1 to 17, wherein at least two optical frequencies are frequency-shifted by the ultrasonic frequency, at least one optical frequency is associated with oxygen-saturated hemoglobin, and at least another optical frequency is associated with non-oxygen-saturated hemoglobin, and wherein the processing unit is configured to compare the detected at least two frequency-shifted optical signals to deduce the ratio of oxygen-saturated hemoglobin to non-oxygen-saturated hemoglobin.

19. The system according to any one of claims 1 to 18, wherein the at least one light emitter is configured to guide light from at least two locations or through an extended region covering the tissue site, thereby providing light propagation paths at different angles.

20. The system according to any one of claims 1 to 19, wherein the at least one light emitter is configured to guide light from at least two locations or by an extended region covering the tissue site, providing a plurality of light injection locations distributed across the surface of the tissue site.

21. The system according to any one of claims 1 to 20, wherein multiple light injection locations and / or light collection locations are used simultaneously or individually, and the detected frequency-shifted light is combined in post-processing.

22. A method for measuring light in humans or animals, the method comprising: Directing at least one ultrasound field having at least one ultrasound frequency to at least one location within the tissue of the human or animal. Light of at least one frequency is directed to the tissue of the human or animal from at least two locations or through an extended area covering the tissue. The at least one optical frequency is suppressed by at least one optical filter arranged in front of at least one photodetector; Transmitted light having at least one optical frequency shifted by the ultrasonic frequency; The light, frequency-shifted by the ultrasonic frequency, is detected by the at least one photodetector; as well as The detected frequency-shifted light from the at least two locations or the extended region is processed to provide information about at least one location within the tissue site.